The cholinergic hypothesis of Alzheimer's disease

Abstract The purpose of this paper is to discuss the usefulness of the central cholinergic deficit hypothesis of Alzheimer's disease (AD) as the basis for a treatment approach in the light of clinical data obtained with velnacrine, a cholinesterase inhibitor. The paper will also try to point out the limitations of the cholinergic treatment strategy and characterize its specificity.